The Bet
Ten years ago Openwater was founded betting that semiconductor manufacturing advances could enable an entirely new breed of medical devices — manipulating light, sound, and electromagnetics in the body in ways never before possible.
The Goal
Something the size and cost of a smartphone that could treat hundreds of diseases — cancers, stroke, mental illness, autoimmune conditions, and even enable BCI and beyond.
The Work
Ten years. Hundreds of prototypes. Testing on phantom tissue, small animals, then people — inventing, refining and architecting toward what the semiconductor supply chain could make at scale.
The Breakthrough
We're now there. Low-cost, pan-disease hardware made on high volume manufacturing lines and a software and AI platform that turns every device into a node in what may become the largest physiological data network ever built.
